Gain/Amplification of Chromosome Arm 1q21 in Multiple Myeloma.

Cancers (Basel) · 2021 · PMC7827173 · PMID 33445467

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

showed a trendp = 0.06so close (0.05 < p ≤ 0.1)

In contrast, RRMM patients with amp(1q21) at relapse showed a trend of a shorter post-relapse survival compared with those with gain(1q21) (5-year post relapse survival rate, amp(1q21) vs. gain(1q21): 0% vs. 32%, p = 0.06).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.